| Literature DB >> 16884300 |
Khuloud Takrouri1, Gal Oren, Itzhack Polacheck, Edward Sionov, Eli Shalom, Jehoshua Katzhendler, Morris Srebnik.
Abstract
A series of new amine cyanoborane derivatives were synthesized and exhibited antifungal activity. A long alkyl chain attached to the nitrogen of the amine cyanoboranes and carboxyboranes enhances antifungal activity. An enhanced activity was also obtained upon the halogenation of the amine cyanoboranes as well as in the presence of C=C double bond at the end of the N-alkyl group. The lead compounds were dimethylundecylamine cyanoborane (C11H23N(CH3)2BH2CN), 9, and its dibromo derivative dimethylundecylamine dibromocyanoborane (C11H23N(CH3)2BBr2CN), 11. The MIC values for the lead compounds against the most important human pathogenic fungi ranged from 16.25 to 32.5 micromol/L and from 10.05 to 79 micromol/L, respectively. Both compounds were found to be relatively safe in intravenous injections to mice, (MTD = 121.9 and 73.1 micromol/kg, respectively) and active against strains that are resistant to fluconazole (a conventional antifungal medicine). These data indicate their potential to become antifungal agents.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16884300 DOI: 10.1021/jm060476e
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446